Net earnings per share (EPS TTM): Solesence Inc. (SLSN)

Corporate company logo of solesence.com (SLSN)

Solesence Inc ensures revenue stability by integrating mineral components into the formulations of global brands. The rolling 12-month net income per share confirms this trend, where the 0.04 mark reflects the latest data. Success is based on the expertise of its staff of chemical technologists and market protection via Kleair technology, which creates significant barriers to entry for new players.

SLSN Solesence Inc Earnings per share for the last 12 months (04/09/2025 - 11/15/2026)

Analytical breakdowns and data insights for company Solesence Inc (SLSN)

- current quotes and average value forecast:
Price Chart Solesence Inc|SLSN - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Capitalization Solesence Inc|SLSN - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Solesence Inc|SLSN - Accounting Capitalization|Market Value to Book Value Ratio solesence.com|SLSN - Company Total Asset Base
- issuer credit burden and liquidity indicators:
Debt to Equity Solesence Inc|SLSN - Long-Term Liabilities to Capital|Short-Term Debt to Equity solesence.com|SLSN - Company Debts|Debts to Book Capitalization Solesence|SLSN - Long-Term Debt|Company Short-Term Debt Solesence Inc|Quick Ratio solesence.com
- earnings and multiples data:
SLSN - Company Net Income|Expected Profit Solesence Inc|SLSN - Price to Earnings Multiple|Forward P/E Multiple Solesence|SLSN - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Solesence|SLSN - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Solesence Inc|SLSN - Earnings per share for the trailing year|Quarterly EPS earnings growth solesence.com|SLSN - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Solesence Inc
- sales volume and revenue information:
SLSN - Company Sales Volume|Projected Sales Volume Solesence|SLSN - Market Cap to Revenue|Price-to-Projected Revenue Ratio Solesence Inc
Fundamental company valuation:solesence.com (SLSN)
Mass-produced product of Solesence Inc.

A conservative investor evaluates business efficiency through Solesence Inc (SLSN) net income per share over 12 months, which reflects the actual return per unit of capital after deducting all expenses. For Solesence Inc (SLSN), this indicator demonstrates how successfully the company monetizes its unique patents in the field of invisible UV filters, allowing for a comparison between the asset's intrinsic value and its market price to determine long-term growth potential.

Main competitors

KRYS - Earnings per share for the last twelve months|APGE - Net earnings per share (EPS TTM)|ARQT: Net earnings per share (EPS TTM)|VCEL - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Oruka Therapeutics|Earnings per share for the last 12 months SMTI (sanaramedtech.com)|Net earnings per share (EPS TTM) DBVT|Earnings per share for the last four quarters DERM|Earnings per share for the last twelve months fortebiorx.com FBRX|EMPG - Net earnings per share for the last 12 months|SLGL - Earnings per share for the last twelve months|Net earnings per share for the last four quarters AXIL Brands AXIL|MDCX: Net earnings per share (EPS TTM)|Verrica Pharmaceuticals Inc - Earnings per share for the trailing year|Net earnings per share for the last 12 months HOTH|BFRI: Earnings per share for the trailing year|Net earnings per share for the last 12 months VYNE (VYNE Therapeutics)|Net earnings per share (EPS TTM) Sonoma Pharma (SNOA)|Earnings per share for the last twelve months Quoin Pharmaceuticals Ltd QNRX|Earnings per share for the trailing year AZTR|DRMA: Net earnings per share for the last 12 months|ELAB: Earnings per share for the last twelve months|RVNC (Revance Therapeutics, Inc) - Net earnings per share for the last 12 months